StockData
Tenaya Therapeutics, Inc. logo

Tenaya Therapeutics, Inc. (TNYA) stock

TNYANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$0.32−0.01 (-3.24%)

Close on Nov 17, 2026Market cap $72.38MP/E –Yield –

Tenaya Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Tenaya Therapeutics's total assets was $93.54M at Jun 30, 2026. For fiscal 2025 it was $146.92M, up 22.5% from the year before. The highest annual figure on record is $314.19M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$146.92M+22.5%
FY2024Dec 31, 2024$119.94M-29.7%
FY2023Dec 31, 2023$170.52M-38.9%
FY2022Dec 31, 2022$278.95M-11.2%
FY2021Dec 31, 2021$314.19M+112.1%
FY2020Dec 31, 2020$148.16M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$93.54M-23.4%
Q1 FY2026Mar 31, 2026$135.07M-6.2%
Q4 FY2025Dec 31, 2025$146.92M+22.5%
Q3 FY2025Sep 30, 2025$104.98M-25.3%
Q2 FY2025Jun 30, 2025$122.15M-25.1%
Q1 FY2025Mar 31, 2025$143.95M-22.1%
Q4 FY2024Dec 31, 2024$119.94M-29.7%
Q3 FY2024Sep 30, 2024$140.58M-27.3%
Q2 FY2024Jun 30, 2024$163.19M-26.1%
Q1 FY2024Mar 31, 2024$184.90M-24.6%
Q4 FY2023Dec 31, 2023$170.52M-38.9%
Q3 FY2023Sep 30, 2023$193.40M-14.5%
Q2 FY2023Jun 30, 2023$220.75M-13.7%
Q1 FY2023Mar 31, 2023$245.34M-12.8%
Q4 FY2022Dec 31, 2022$278.95M-11.2%
Q3 FY2022Sep 30, 2022$226.31M-31.8%
Q2 FY2022Jun 30, 2022$255.93M+63.1%
Q1 FY2022Mar 31, 2022$281.50M+90.0%
Q4 FY2021Dec 31, 2021$314.19M–
Q3 FY2021Sep 30, 2021$331.79M–
Q2 FY2021Jun 30, 2021$156.90M–
Q4 FY2020Dec 31, 2020$148.16M–

More Tenaya Therapeutics figures

See a number that looks wrong?